参考文献/References:
[1] Mcmullen J R,Jennings G L.Differences between pathologicaland physiological cardiac hypertrophy:novel therapeuticstrategies to treat heart failure[J].Clinical and ExperimentalPharmacology and Physiology 2007,34(4):255-262.[2] 曾紫凡,王勇,李春,等.心肌纤维化的发病机制和治疗进展[J].中西医结合心血管病电子杂志,2016,4(27):13-15.[3] 董丽,姜国旺,樊瑞红.中医药治疗高血压病的机制研究[J].天津中医药大学学报,2018,37(3):261-264.[4] Kong P,Christia P,Frangogiannis N G.The pathogenesis ofcardiac fibrosis[J].Cellular and Molecular Life Sciences,2014,71(4):549-574.[5] 谢志翔,陈科,梁智敏,等.真武汤逆转大鼠心肌肥厚的病理学研究[J].中华临床医师杂志(电子版),2012,6(1):103-106.[6] Patel S,Rauf A,Khan H,et al.Renin-angiotensin-aldosterone(RAAS):The ubiquitous system for homeostasis andpathologies[J].Biomedicine & Pharmacotherapy,2017,94:317-325.[7] 马金,丁春华.心脏成纤维细胞与心肌纤维化[J].中国心血管病杂志,2014,42(3):269-272.[8] 虞东玲,汪涛,郑偕扣,等.降压清心方对高血压大鼠心肌纤维化及神经内分泌影响的实验研究[J].山西中医,2011,27(10):46-48.[9] 胡坤媚,胡浩然,沈媛媛,等.中药玉夏胶囊对自发性高血压大鼠肾纤维化的改善作用及 TGF-β_1/Smads 信号通路的影响[J].中国临床药理学与治疗学,2017,22(4): 387-393.[10] 邱智东.参草菌质对大鼠心肌纤维化的抑制作用及机制- 83 -研究[D].长春:长春中医药大学,2016.[11] Li J M,Gall N P,Grieve D J,et al.Activation of NADPHoxidase during progression of cardiac hypertrophy to failure[J].Hypertension,2002,40(4):477-484.[12] Zeng J,Zhao J,Dong B,et al.Lycopene protects againstpressure overload-induced cardiac hypertrophy by attenuatingoxidative stress[J].Journal of Nutritional Biochemistry,2019,66:70-78.[13] 王瑞钰,薛倩,黄晶.氧化应激与压力感受器敏感性在高血压治疗中的研究进展[J].心血管病学进展,2019(1):45-48.[14] Wu Y,Qian Z,Fu S,et al.IcarisideII improves left ventricularremodeling in spontaneously hypertensive rats by inhibitingthe ASK1-JNK/p38 signaling pathway[J].European JournalPharmacol,2018,819:68-79.[15] Yang M,Xiong J,Zou Q,et al.Chrysin attenuates interstitialfibrosis and improves cardiac function in a rat model ofacute myocardial infarction[J].Journal of Molecular Histology,2018,49(6):555-565.[16] 束长城,魏万林.高血压左心室肥厚的形成机制研究进展[J].中国循证心血管医学杂志,2018,10(6):760-762.[17] Dehlin H M,Manteufel E J,Monroe A L,et al.Substance Pacting via the neurokinin-1 receptor regulates adversemyocardial remodeling in a rat model of hypertension[J].International Journal of Cardiology,2013,168(5):4643-4651.[18] Liu R M,Pravia K A G.Oxidative stress and glutathione inTGF-β-mediated fibrogenesis[J].Free Radical Biology &Medicine,2010,48(1):1-15.[19] Shen N,Li X,Zhou T,et al.Shensong Yangxin Capsuleprevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling[J].Journal of Ethnopharmacology,2014,157:161-170.[20] Kumari P,Saifi M A,Khurana A,et al.Cardioprotectiveeffects of nanoceria in a murine model of cardiacremodeling[J].Journal of Trace Elements in Medicine andBiology,2018,50:198-208.[21] Rosin N L,Sopel M,Falkenham A,et al.Myocardial migrationby fibroblast progenitor cells is blood pressure dependent ina model of angII myocardial fibrosis[J].HypertensionResearch,2012,35(4):449-456.[22] 郝秀珍,肖延龄,王兴.安宫降压丸治疗肝阳上亢证原发性高血压的临床观察[J].中华中医药杂志,2016,31(8):3362-3364.[23] 李娇,赵信科,魏惠平,等.Wnt 信号通路与心肌纤维化的研究进展和应用前景[J].中国临床药理学杂志,2017,33(18):1828-1831[24] Zhao Y,Wang C,Wang C,et al.An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease[J].Scientific Reports,2018,8(1):8996.[25] 辛国,赵昕彤,黄晓巍.柴胡化学成分及药理作用研究进展[J].吉林中医药,2018,38(10):1196-1198.[26] Liu Y,Gao L,Zhao X,et al.Saikosaponin A protects frompressure overload-induced cardiac fibrosis via inhibitingfibroblast activation or endothelial cell EndMT[J].International Journal of Biological Sciece.2018,14(13):1923-1934.[27] 苗艳菊,杨敏,郑娇,等.Akt1 在高血压心肌纤维化中的作用及其机制[J].中华高血压杂志,2013,21(3):265-271.[28] Song J,Liu Q,Tang H,et al.Activation of PI3Kγ/Akt pathwayincreases cardiomyocyte HMGB1 expression in diabeticenvironment[J].Oncotarget,2016,7(49):80803-80810.[29] Lu L,Wang J,Wu Y,et al.GW26-e1056 Qishenyiqi attenuatesmyocardial fibrosis in rats by inhibiting RAAS-mediatedarachidonic acid inflammation[J].Journal of the AmericanCollege of Cardiology,2015,66(16):C103-C104.[30] Jongmin L,Levin D E,Lew D J.Intracellular mechanism bywhich arsenite activates the yeast stress MAPK Hog1[J].Molecular Biology of the Cell,2018,29(15):1904-1915.[31] Kojonazarov B,Novoyatleva T,Boehm M,et al.p38 MAPKinhibition improves heart function in pressure-loaded rightventricular hypertrophy[J].American Journal of RespiratoryCell and Molecular Biology,2017,57(5):603-614.[32] Liu X,Chen K,Zhuang Y,et al.Paeoniflorin improves pressureoverload-induced cardiac remodeling by modulating theMAPK signaling pathway in spontaneously hypertensiverats[J].Biomed Pharmacother,2019,111:695-704.[33] Guanhua F,Shaoqin C,Qiuyu H,et al.Curcumin suppressescardiac fibroblasts activities by regulating the proliferationand cell cycle via the inhibition of the p38 MAPK/ERKsignaling pathway[J].Molecular Medicine Reports,2018,18(2):1433-1435.[34] Zhao W,Li Y,Jia L,et al.Atg5 deficiency-mediated mitophagyaggravates cardiac inflammation and injury in response toangiotensin II[J].Free Radical Biology and Medicine,2014,69:108-115.[35] Li M H,Zhang Y J,Yu Y H,et al.Berberine improves pressureoverload-induced cardiac hypertrophy and dysfunctionthrough enhanced autophagy[J].European Journal ofPharmacology,2014,728:67-76.
相似文献/References:
[1]李瑞祥 陈斯宁.中医药对 COPD 大鼠模型作用机理的研究进展[J].大众科技,2014,16(05):95.
[2]廖咸硕.慢性乙型肝炎中医药治疗进展[J].大众科技,2014,16(10):124.
Progress in the treatment of chronic hepatitis B with traditional Chinese medicine[J].Popular Science & Technology,2014,16(06):124.
[3]李鹏程 韦艾凌 张永琴 唐秋媛.中医药调控肝癌血管生成的研究近况[J].大众科技,2014,16(11):136.
Research status on traditional Chinese medicine of angiogenesis inhepatocellular carcinoma[J].Popular Science & Technology,2014,16(06):136.
[4]万 媛.中医药协同治疗卒中后抑郁症的研究近况[J].大众科技,2014,16(12):98.
The recent clinical research of Chinese-western therapy on post-stroke depression[J].Popular Science & Technology,2014,16(06):98.
[5]杨 赟 梁爱武.中医药对慢性阻塞性肺疾病MMP-9、TIMP-1 影响的研究进展[J].大众科技,2015,15(02):78.
慢性阻塞性肺疾病；基质金属蛋白酶-9；金属蛋白酶组织抑制-1；气道重塑；中医药[J].Popular Science & Technology,2015,15(06):78.
[6]张艳娟,吴 光.中医药院校助力精准扶贫工作研究——以广西中医药大学定点扶贫为例[J].大众科技,2019,21(09):129.
Research on Targeted Poverty Alleviation Work in Colleges and Universities of Traditional Chinese Medicine ——Take Guangxi University of Traditional Chinese Medicine as an Example[J].Popular Science & Technology,2019,21(06):129.
[7]陈曹华 李沛桢 周华亮 马潍珩 刘汝专.中医药治疗腰椎间盘突出症术后残留症状的研究进展[J].大众科技,2022,24(06):112.
Research Status of Postoperative Residual Symptoms of Lumbar Intervertebral Disc Herniation Treated with Traditional Chinese Medicine[J].Popular Science & Technology,2022,24(06):112.
[8]桂雄斌 伏广虎.中医药治疗变应性鼻炎研究进展[J].大众科技,2018,20(06):61.
[9]韦卓 伍燕宏 郑景辉.血府逐瘀汤治疗心血管病的研究进展[J].大众科技,2018,20(06):63.
[10]兰鹏潘凤仙苏锦勋.脑卒中后肩手综合征的中医药外治法研究进展[J].大众科技,2018,20(06):71.